Manhattan Research has just released its annual ePharma Physician® study looking at how physicians are engaging with biopharma firms through digital media. ePharma Physician® 2013 offers insight into the critical issues facing brand managers in strategic planning around multichannel marketing, including: the continuing evolution of the iPad-equipped sales rep; allocating digital professional investment between third-party properties and proprietary sites and apps; and helping customers adjust to a post-Affordable Care Act landscape in which formulary considerations are foremost in guiding prescribing decisions.
This complimentary white paper is just a small preview of in-depth data and analysis available to subscribing clients of the ePharma Physician® study.
Please sumbit the below form to access the white paper:
I consent to receive e-mails from DRG regarding healthcare market information, product announcements, promotions, webinar and seminar invitations and other messages. I understand that I may withdraw my consent and unsubscribe or update my email preferences
and contact us with any questions.
is Manhattan Research’s market research study and syndicated advisory service exploring physician adoption of digital channels for prescription drug information, including through various types of online promotion programs and customer service options from pharma companies. Tablet-assisted in-person sales interactions and their impact on clinical decisions and satisfaction are also assessed. ePharma Physician® 2013 was fielded online in Q2 2013 among 1,831 physicians who are ePharma Physicians, or who use digital channels for pharma resources and connecting with reps. The data can be segmented across a variety of target specialist audiences, including PCPs, pediatricians, cardiologists, oncologists, gastroenterologists and OB/GYNs.
For additional information, please visit the ePharma Physician® product page for more information, contact email@example.com, or call 1.888.680.0800, ext. 2.